Análisis y categorización de las consultas farmacoterapéuticas recibidas en un Centro de Información de Medicamentos de Valencia

  1. S. Gutiérrez-Igual 1
  2. R. Lucas-Domínguez 2
  3. I. Romero Crespo 3
  4. M. Montesinos 2
  1. 1 Departamento de Farmacología. Universidad de Valencia
  2. 2 Departamento de Historia de la Ciencia y Documentación. Facultad de Medicina y Odontología. Universidad de Valencia
  3. 3 Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia
Erakutsi afiliazioak +
Aldizkaria:
Farmacéuticos comunitarios

ISSN: 1885-8619

Argitalpen urtea: 2024

Alea: 16

Zenbakia: 4

Mota: Artikulua

DOI: 10.33620/FC.2173-9218.(2024).24 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Farmacéuticos comunitarios

Laburpena

Introduction: Drug Information Services (DIS) act as a source of technical and scientific information of drugs and medical devices, promoting their rational use. Objectives: To analyze and classify, according to standardized criteria, the pharmacotherapeutic queries, therapeutic groups, and drugs most frequently consulted at the DIS of the Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF). Methodology: An ambispective and cross-sectional observational study was conducted from June 1, 2021, to June 1, 2022. A total of 445 inquiries made by pharmacists from the province of Valencia were registered and analyzed, collecting the following data: drug, ATC-4 therapeutic group, and pharmacotherapeutic category of the query. Results: The most frequently consulted categories were commercialization and safety, with Proton Pump Inhibitors (PPIs, A02BC) and Vitamin K Antagonists (VKAs, B01AA) being the most consulted pharmacological groups, accounting for 2.7% and 2.3% of the total inquiries respectively. Regarding classification, 90,0% of the inquiries about acenocoumarol were about drug interactions, while 33.3% of the inquiries about PPIs were related to commercialization. Conclusions: The analysis of the inquiries received has made possible to identify the therapeutic groups, drugs and pharmacotherapeutic categories that generate the highest number of inquiries. This information is valuable for improving the efficiency of responses at the DIS, providing uniformity, and reducing errors. Additionally, it provides a comprehensive database that facilitates the standardized integration of information.

Erreferentzia bibliografikoak

  • Gabay MP. The Evolution of Drug Information Centers and Specialists. Hosp Pharm. 2017;52(7):452-3. https://doi.org/10.1177/0018578717724235
  • Pla R, García D, Martín MI, Porta A. Información de medicamentos. Farmacia hospitalaria. Tomo I. SEFH; 2002;2(8):507-40. Disponible en https://www.sefh.es/bibliotecavirtual/fhtomo1/cap28.pdf#:~:text=R.%20PLA.%20D.%20GARC%C3%8DA.%20M.%20I.
  • Escalante-Saavedra PA, Marques-Batista G, Maniero HK, Bedatt-Silva R, Calvo-Barbado DM. Brazilian Drug Information Centre: descriptive study on the quality of information 2010-2015. Farm Hosp. 2017;41(3):334-45. https://doi.org/10.7399/fh.2017.41.3.10641
  • Ali A, Mohd Yusoff S, Mohd Joffry S, Wahab MS. Drug information service awareness program and its impact on characteristics of inquiries at DIS unit in Malaysian public hospital. Arch Pharm Pract. 2013;4(1):9. https://shorturl.at/u0H1q
  • Hunashal R, Kudagi B, Kamadod M, Biradar S. Drug Information Center. The Internet Journal of Medical Informatics. 2007;4(1):12. Disponible en https://api.semanticscholar.org/CorpusID:40809851
  • MICOF de Valencia. Centro de información de medicamentos (CIM) [Internet]. MICOF - Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia. [citado 3 de junio de 2024]. Disponible en: https://www.micof.es/ver/4220/centro-de-informacion-de-medicamentos-cim.html
  • Fernández VJB. Estudio de las consultas farmacoterapéuticas de información de medicamentos en la farmacia comunitaria [tesis doctoral]. Universidad CEU - Cardenal Herrera; 2016 [citado 23 de junio de 2024]. Disponible en: https://repositorioinstitucional.ceu.es/bitstream/10637/8393/4/Estudio_Baixauli_UCHCEU_Tesis_2016.pdf
  • Boletín INFAC [Internet]. Dónde buscar información sobre medicamentos. 2024;32(4) [citado 8 de abril de 2024]. Disponible en: https://www.euskadi.eus/contenidos/informacion/cevime_infac_2024/es_def/adjuntos/INFAC_Vol_32_4_informacion-medicamentos.pdf
  • Informe Prestación farmacéutica 2020-21 [Internet]. [citado 27 de junio de 2024]. Disponible en: https://www.sanidad.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/InfAnualSNS2020_21/Informe_PrestacionFarmaceutica_2020-21.pdf
  • Almuqbil M, Alrojaie L, Alturki H, Alhammad A, Alsharawy Y, Alkoraishi A, et al. The role of drug information centers to improve medication safety in Saudi Arabia - a study from healthcare professionals’ perspective. Saudi Pharmaceutical Journal. 2022;30(4):377-81. https://doi.org/10.1016/j.jsps.2022.01.024
  • Amundstuen Reppe L, Spigset O, Schjøtt J. Drug Information Services Today: Current Role and Future Perspectives in Rational Drug Therapy. Clin Ther. 2016;38(2):414-21. https://doi.org/10.1016/j.clinthera.2015.12.019
  • Almazrou DA, Ali S, Alzhrani JA. Assessment of Queries Received by the Drug Information Center at King Saud Medical City. J Pharm Bioallied Sci. 2017;9(4):246-50. https://doi.org/10.4103/jpbs.jpbs_166_17
  • Alamri SA, Ali Al Jaizani R, Naqvi AA, Ghamdi MSA. Assessment of Drug Information Service in Public and Private Sector Tertiary Care Hospitals in the Eastern Province of Saudi Arabia. Pharm J Pharm Educ Pract. 2017;5(3):37. https://doi.org/10.3390/pharmacy5030037
  • Jiménez Labaig L, Jiménez Galán ER. La farmacia comunitaria como centro de información del medicamento fiable y accesible al paciente. Farm Comunitarios. 2012;4(1). https://shorturl.at/N8YwJ
  • Gutiérrez-Igual S, Lucas-Domínguez R, Martí Rodrigo A, Romero Crespo I, Montesinos Mezquita MC. Nuevas herramientas para la revisión de la medicación: PRM en pacientes en tratamiento con inhibidores de la bomba de protones. Aten Primaria. 2023;56(5):102836. https://doi.org/10.1016/j.aprim.2023.102836
  • Behera SK, Xavier AS, Gunaseelan V, Ravindra BK, Selvarajan S, Chandrasekaran A, et al. Drug information center as referral service in a South Indian tertiary care hospital. Int J Pharm Investig. 2017;7(4):182-7. https://doi.org/10.4103/jphi.jphi_90_17
  • Ávila M, Papuzinski C, Ahumada S, Vidal C. Factores asociados a INR fuera de rango terapéutico en usuarios de terapia anticoagulante oral con antagonistas de vitamina K. Rev Chil Cardiol. 2014;33(1):33-7. http://dx.doi.org/10.4067/S0718-85602014000100004
  • López B, Murgadella A, Padullés A, Serrano O, Roca M, March M. Acenocumarol. Estudio de sus interacciones en pacientes hospitalizados. OFFARM. 2006;25(5):90-5.
  • Harish C, Belavigi D, Patil AN, Pattanaik S, Kakkar A, Kasudhan KS. Assessment of the Impact of Clinical Pharmacology Consultations Provided to Hospital Clinicians From the Drug Information Center—An Outcome Research in a Developing Country. J Pharm Pract. 2021;34(4):581-6. https://doi.org/10.1177/0897190019885256
  • Kumar-M P, Patil A, Kakkar AK, Singh H. Decoding the Roadmap for Capacity Building of Pharmacology Academicians in Catering to Drug Information Center Services in a Developing Country. J Pharm Technol JPT Off Publ Assoc Pharm Tech. 2019;35(4):146-54. https://doi.org/10.1177%2F8755122519841364
Datuen iturria: Dialnet